home
investors
newsroom
licensing
careers
contact us
About Us
Our Values
Leadership
How We Operate
Views and Positions
Merck/Schering-Plough Merger
Our History
Corporate Responsibility
Ethics and Transparency
Access
Environment
Community
Research
Pipeline
Discovery & Development
Products
Vaccines
Prescription Products
Consumer Products
Animal Health
Prescribing Information
INVESTED IN
YOUR FUTURE
Financials
Annual Reports, Proxy Statements, and Form 10-K
SEC Filings & Certifications
Earnings Releases
Quarterly Financials
Stock Information
Stock Chart
Historical Price Lookup
Stock Splits
Cash Dividend History
Investment Calculator
Partnerships
Events & Presentations
Stockholder Services
Information Request
Contact Us
LATEST NEWS
more news
Sep. 01, 2010
BRINAVESS
™
(vernakalant) for Infusion Approved in the European Union for Rapid Conversion of Recent Onset Atrial Fibrillation
Aug. 24, 2010
Merck Provides New Funding to Fight HIV/AIDS in Botswana
Aug. 24, 2010
New DR. SCHOLL'S
®
FOR HER Fast Flats
™
Offer a Practical Solution For a Long Day or Night in Heels
Print
Share
Text Size
Related Information
2009 Merck Annual Report
Corporate Responsibility Report
Product Pipeline
Learn more
Podcast
